Bristol Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.
See below for the Latest Bristol Myers Squibb News, Analysis, Profit Results, Share Price Information, and Commentary.
Bristol-Myers Squibb Japan wins Digital Innovation of the Year
Bristol-Myers Squibb Japan wins Digital Innovation of the Year
It was awarded for its PSP@SNS Platform at the Healthcare Asia Pharma Awards.
Join the community
Most Read
1. Sunway Healthcare targets $4.34b market cap with Malaysia IPO 2. 2026 biotech playbook: Hong Kong at the centre of China’s globalisation 3. Aging population drives demand for durable medical equipment market 4. IHH Healthcare FY2025 net profit falls 21% to $682.67m 5. Tam Anh invests $77m in proton therapy systemResource Center
Events
Event News
Co-Written / Partner
Pureland Venture’s Chris Hardesty: Governments must sustain long-term focus on healthcare innovation, technology
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation